Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Depreciation and Depletion: 2020-2024

Historic Depreciation and Depletion for Cardiol Therapeutics (CRDL) over the last 5 years, with Dec 2024 value amounting to $118,877.

  • Cardiol Therapeutics' Depreciation and Depletion fell 6.60% to $25,582 in Q3 2022 from the same period last year, while for Sep 2022 it was $104,223, marking a year-over-year change of. This contributed to the annual value of $118,877 for FY2024, which is 2.15% down from last year.
  • As of FY2024, Cardiol Therapeutics' Depreciation and Depletion stood at $118,877, which was down 2.15% from $121,485 recorded in FY2023.
  • In the past 5 years, Cardiol Therapeutics' Depreciation and Depletion registered a high of $121,485 during FY2023, and its lowest value of $104,194 during FY2022.
  • Over the past 3 years, Cardiol Therapeutics' median Depreciation and Depletion value was $118,877 (recorded in 2024), while the average stood at $114,852.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first dropped by 3.97% in 2022, then grew by 16.59% in 2023.
  • Over the past 5 years, Cardiol Therapeutics' Depreciation and Depletion (MRY) stood at $108,310 in 2020, then grew by 0.18% to $108,504 in 2021, then fell by 3.97% to $104,194 in 2022, then increased by 16.59% to $121,485 in 2023, then decreased by 2.15% to $118,877 in 2024.
  • Its Depreciation and Depletion was $118,877 in FY2024, compared to $121,485 in FY2023 and $104,194 in FY2022.